Old Web
English
Sign In
Acemap
>
authorDetail
>
Stephan G. Klinz
Stephan G. Klinz
Ipsen
Medicine
Cancer research
Pancreatic cancer
Liposomal Irinotecan
Cabozantinib
4
Papers
2
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Antitumor effects of the multi-target tyrosine kinase inhibitor cabozantinib: a comprehensive review of the preclinical evidence.
2021
Expert Review of Anticancer Therapy
Matteo Santoni
Roberto Iacovelli
Valentina Colonna
Stephan G. Klinz
Giorgio Mauri
Marianna Nuti
Show All
Source
Cite
Save
Citations (1)
Abstract PO053: Efficacy of cabozantinib after immune checkpoint inhibition in a syngeneic tumor model
2021
Cancer immunology research
Sylvie Rolland
Stephan G. Klinz
Sophie Chaumeron
Florence Meyer-Losic
Marc Hillairet de Boisferon
Show All
Source
Cite
Save
Citations (0)
Differentiation of liposomal irinotecan from dose-dense non-liposomal irinotecan in patient-derived pancreatic cancer xenograft tumor models.
2020
Journal of Clinical Oncology
Sandrine Barbier
Stephane Lezmi
Benjamin Beaufils
Adreanne Lortie
Marc Hillairet de Boisferon
Sophie Chaumeron
Anne Espirito
Stephan G. Klinz
Arunthathi Thiagalingam
Florence Meyer-Losic
Show All
Source
Cite
Save
Citations (0)
Longitudinal PET Imaging to Monitor Treatment Efficacy by Liposomal Irinotecan in Orthotopic Patient-Derived Pancreatic Tumor Models of High and Low Hypoxia
2019
Molecular Imaging and Biology
Manuela Ventura
Nicholas Bernards
Raquel De Souza
Inga B. Fricke
Bart S. Hendriks
Jonathan Basil Fitzgerald
Helen Lee
Stephan G. Klinz
Jinzi Zheng
Show All
Source
Cite
Save
Citations (1)
1
map